Posts

Showing posts from September, 2026

Why It Takes 24-36 Months to Break Even on Your Own Plant, But Only 3-6 Months Through Third-Party Manufacturing

  Direct answer: the gap comes down to two things stacking on top of each other before you sell a single unit — the capital you have to recover, and the time you have to wait before you're even legally allowed to sell. Build your own facility, and both of these work against you at once. Go through third-party manufacturing, and both nearly disappear. What's Actually Being Compared Starting a medicine manufacturing business in India comes down to one core decision: build an independent facility, or manufacture through an existing WHO-GMP certified partner. The numbers behind that decision are stark — an independent plant requires ₹80 lakh to ₹2 crore in machinery and cleanroom construction alone, plus ₹3 lakh to ₹8 lakh in licensing fees and ₹20 lakh to ₹50 lakh in working capital. The third-party route needs none of the plant investment, ₹20,000 to ₹50,000 in licensing, and just ₹2 lakh to ₹5 lakh in working capital. That difference in upfront cost is well known. What's les...

Does Pushkar Pharma Export to Africa? Here's Exactly Where They Ship

  Direct answer: yes. Pushkar Pharma currently exports to 17 countries across three regions — Africa, Central Asia, and Eastern Europe — supplying injectables, ophthalmic formulations, and general pharmaceutical products to distributors and government tenders in each. Which African Countries Does Pushkar Pharma Export To? Ten African countries: Algeria, Ethiopia, Ghana, Kenya, Mozambique, Nigeria, Namibia, Sierra Leone, Tanzania, and Zambia. This is the largest single region in Pushkar Pharma's current export footprint, and it's not a coincidence — Africa represents some of the fastest-growing pharmaceutical import demand globally, with many national health systems relying heavily on certified generic and injectable imports rather than domestic manufacturing. Each of these markets has its own national drug regulator, and Pushkar Pharma aligns its export documentation to the specific authority governing each one: Country Regulatory Alignment Ethiopia EFDA (Ethiopian Food and Dru...

Negotiating a Third-Party Injection Manufacturing Agreement in India: What the Contract Actually Needs to Cover

  Here's something most buyers don't realize until it costs them: India's Drugs and Cosmetics Act and its accompanying Rules don't specifically legislate contract manufacturing arrangements. The law is largely silent on how quality responsibility, formulation ownership, and liability should be divided between a brand owner and a third-party manufacturer. That gap doesn't get filled by regulation — it gets filled by whatever the manufacturing agreement actually says. Which means the contract itself, not just the certifications on the wall, is where a lot of the real risk in third-party injection manufacturing either gets managed or gets ignored. This piece looks at what a manufacturing agreement should actually cover before you sign, the red flags that catch most bad partnerships before they cost real money, and what the standard process looks like once you're ready to move forward. What a Third-Party Injection Manufacturing Agreement Should Actually Define A va...

What is third-party manufacturing in pharma?

  Third-party manufacturing in pharma is when a brand owner outsources drug production to a licensed, WHO-GMP certified manufacturer, then sells the finished medicines under its own brand name. The manufacturer handles the factory, raw materials, and quality testing; the brand owner focuses on branding and distribution. This model has become one of the most accessible ways to enter India's pharma business in 2026, letting startups and PCD franchise businesses launch products without capital-heavy infrastructure. Compare the top 10 WHO-GMP certified companies and full process breakdown in the complete guide.